PEN-VEE K Drug Patent Profile

Which patents cover Pen-vee K, and when can generic versions of Pen-vee K launch?

Pen-vee K is a drug marketed by Wyeth Ayerst and is included in two NDAs.

The generic ingredient in PEN-VEE K is penicillin v potassium. There are ninety-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pen-vee K

A generic version of PEN-VEE K was approved as penicillin v potassium by CHARTWELL RX on November 23^rd, 1988.

Summary for PEN-VEE K

US Patents:	0
Applicants:	1
NDAs:	2

US Patents and Regulatory Information for PEN-VEE K

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Ayerst	PEN-VEE K	penicillin v potassium	FOR SOLUTION;ORAL	060007-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Wyeth Ayerst	PEN-VEE K	penicillin v potassium	TABLET;ORAL	060006-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Wyeth Ayerst	PEN-VEE K	penicillin v potassium	FOR SOLUTION;ORAL	060007-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Wyeth Ayerst	PEN-VEE K	penicillin v potassium	TABLET;ORAL	060006-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Wyeth Ayerst	PEN-VEE K	penicillin v potassium	TABLET;ORAL	060006-003	Approved Prior to Jan 1, 1982		DISCN	No	No